Literature DB >> 23201228

Hippocampal volume and total cell numbers in major depressive disorder.

Justin A Cobb1, Joy Simpson, Gouri J Mahajan, James C Overholser, George J Jurjus, Lesa Dieter, Nicole Herbst, Warren May, Grazyna Rajkowska, Craig A Stockmeier.   

Abstract

Neuroimaging consistently reveals smaller hippocampal volume in recurrent or chronic major depressive disorder (MDD). The underlying cellular correlates of the smaller volume are not clearly known. Postmortem tissues from 17 pairs of depressed and control subjects were obtained at autopsy, and informant-based retrospective psychiatric assessment was performed. Formalin-fixed left temporal lobes were sectioned (40 μm), stained for Nissl substance, and every 60th section selected throughout the entire hippocampus. Total volume of the hippocampal formation was calculated, and total numbers of pyramidal neurons (in hippocampal fields CA1, CA2/3, hilus), dentate gyrus (DG) granule cells, and glial cells were estimated stereologically. While hippocampal volume in all MDD subjects was not significantly smaller versus control subjects, in recurrent/chronic MDD, total volume decreased with duration of depressive illness (r = -0.696, p < 0.026). There was no significant difference between MDD and controls in total number or density of pyramidal neurons/granule cells or glial cells in CA1, CA2/3, hilus, or DG. However, CA1 pyramidal neuron density increased with duration of illness in recurrent/chronic MDD (r = 0.840, p < 0.002). Granule cell (r = 0.971, p < 0.002) and glial cell numbers (r = 0.980, p < 0.001) increased with age in those taking antidepressant medication (n = 6). Increasing DG granule cell and glial cell numbers with age in antidepressant-treated subjects may reflect proliferative effects of antidepressant medications. Decreasing total volume and increasing CA1 pyramidal neuron density with duration of illness in recurrent/chronic MDD lends support to the neuropil hypothesis of MDD.
Copyright © 2012 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Year:  2012        PMID: 23201228      PMCID: PMC3757567          DOI: 10.1016/j.jpsychires.2012.10.020

Source DB:  PubMed          Journal:  J Psychiatr Res        ISSN: 0022-3956            Impact factor:   4.791


  46 in total

Review 1.  A neurotrophic model for stress-related mood disorders.

Authors:  Ronald S Duman; Lisa M Monteggia
Journal:  Biol Psychiatry       Date:  2006-04-21       Impact factor: 13.382

Review 2.  Hippocampal sulcal cavities: prevalence, risk factors and relationship to memory impairment.

Authors:  Jerome J Maller; Chantal Réglade-Meslin; Patrick Chan; Zafiris J Daskalakis; Richard H S Thomson; Kaarin J Anstey; Marc Budge; Perminder Sachdev; Paul B Fitzgerald
Journal:  Brain Res       Date:  2010-10-30       Impact factor: 3.252

Review 3.  The role of BDNF and its receptors in depression and antidepressant drug action: Reactivation of developmental plasticity.

Authors:  Eero Castrén; Tomi Rantamäki
Journal:  Dev Neurobiol       Date:  2010-04       Impact factor: 3.964

Review 4.  The role of BDNF in depression on the basis of its location in the neural circuitry.

Authors:  Hui Yu; Zhe-yu Chen
Journal:  Acta Pharmacol Sin       Date:  2010-12-06       Impact factor: 6.150

Review 5.  How does electroconvulsive therapy work? Theories on its mechanism.

Authors:  Tom G Bolwig
Journal:  Can J Psychiatry       Date:  2011-01       Impact factor: 4.356

6.  The MAP kinase phosphatase MKP-1 regulates BDNF-induced axon branching.

Authors:  Freddy Jeanneteau; Katrin Deinhardt; Goichi Miyoshi; Anton M Bennett; Moses V Chao
Journal:  Nat Neurosci       Date:  2010-10-10       Impact factor: 24.884

7.  The epidemiology of major depressive disorder: results from the National Comorbidity Survey Replication (NCS-R).

Authors:  Ronald C Kessler; Patricia Berglund; Olga Demler; Robert Jin; Doreen Koretz; Kathleen R Merikangas; A John Rush; Ellen E Walters; Philip S Wang
Journal:  JAMA       Date:  2003-06-18       Impact factor: 56.272

8.  Sex differences in temporo-limbic and frontal brain volumes of healthy adults.

Authors:  Ruben C Gur; Faith Gunning-Dixon; Warren B Bilker; Raquel E Gur
Journal:  Cereb Cortex       Date:  2002-09       Impact factor: 5.357

9.  Hippocampal atrophy in recurrent major depression.

Authors:  Y I Sheline; P W Wang; M H Gado; J G Csernansky; M W Vannier
Journal:  Proc Natl Acad Sci U S A       Date:  1996-04-30       Impact factor: 11.205

10.  Hippocampal volumetrics in depression: the importance of the posterior tail.

Authors:  Jerome J Maller; Z Jeff Daskalakis; Paul B Fitzgerald
Journal:  Hippocampus       Date:  2007       Impact factor: 3.899

View more
  42 in total

1.  Length of axons expressing the serotonin transporter in orbitofrontal cortex is lower with age in depression.

Authors:  Grazyna Rajkowska; Gouri Mahajan; Beata Legutko; Lavanya Challagundla; Michael Griswold; Paul R Albert; Mireille Daigle; Jose J Miguel-Hidalgo; Mark C Austin; Randy D Blakely; David C Steffens; Craig A Stockmeier
Journal:  Neuroscience       Date:  2017-07-13       Impact factor: 3.590

Review 2.  Searching human brain for mechanisms of psychiatric disorders. Implications for studies on schizophrenia.

Authors:  Sabina Berretta; Stephan Heckers; Francine M Benes
Journal:  Schizophr Res       Date:  2014-11-11       Impact factor: 4.939

3.  Adult neuroplasticity: A new “cure” for major depression?

Authors:  Paul R. Albert
Journal:  J Psychiatry Neurosci       Date:  2019-03-01       Impact factor: 6.186

4.  GABAergic control of depression-related brain states.

Authors:  Bernhard Luscher; Thomas Fuchs
Journal:  Adv Pharmacol       Date:  2015-01-14

5.  Altered neuro-inflammatory gene expression in hippocampus in major depressive disorder.

Authors:  Gouri J Mahajan; Eric J Vallender; Michael R Garrett; Lavanya Challagundla; James C Overholser; George Jurjus; Lesa Dieter; Maryam Syed; Damian G Romero; Hamed Benghuzzi; Craig A Stockmeier
Journal:  Prog Neuropsychopharmacol Biol Psychiatry       Date:  2017-11-22       Impact factor: 5.067

6.  Resilience Is Associated With Larger Dentate Gyrus, While Suicide Decedents With Major Depressive Disorder Have Fewer Granule Neurons.

Authors:  Maura Boldrini; Hanga Galfalvy; Andrew J Dwork; Gorazd B Rosoklija; Iskra Trencevska-Ivanovska; Goran Pavlovski; René Hen; Victoria Arango; J John Mann
Journal:  Biol Psychiatry       Date:  2019-01-17       Impact factor: 13.382

Review 7.  Type A monoamine oxidase and serotonin are coordinately involved in depressive disorders: from neurotransmitter imbalance to impaired neurogenesis.

Authors:  Makoto Naoi; Wakako Maruyama; Masayo Shamoto-Nagai
Journal:  J Neural Transm (Vienna)       Date:  2017-03-14       Impact factor: 3.575

8.  Neuroprotective kynurenine metabolite indices are abnormally reduced and positively associated with hippocampal and amygdalar volume in bipolar disorder.

Authors:  Jonathan Savitz; Robert Dantzer; Brent E Wurfel; Teresa A Victor; Bart N Ford; Jerzy Bodurka; P S F Bellgowan; T Kent Teague; Wayne C Drevets
Journal:  Psychoneuroendocrinology       Date:  2014-11-24       Impact factor: 4.905

9.  Density of GFAP-immunoreactive astrocytes is decreased in left hippocampi in major depressive disorder.

Authors:  J A Cobb; K O'Neill; J Milner; G J Mahajan; T J Lawrence; W L May; J Miguel-Hidalgo; G Rajkowska; C A Stockmeier
Journal:  Neuroscience       Date:  2015-12-30       Impact factor: 3.590

10.  Cell number and neuropil alterations in subregions of the anterior hippocampus in a female monkey model of depression.

Authors:  Stephanie L Willard; David R Riddle; M Elizabeth Forbes; Carol A Shively
Journal:  Biol Psychiatry       Date:  2013-04-19       Impact factor: 13.382

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.